Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.
Bactiguard Holding AB's operating assets for the quarter that ended in Mar. 2026 was kr502.0 Mil. Bactiguard Holding AB's operating liabilities for the quarter that ended in Mar. 2026 was kr64.4 Mil. Bactiguard Holding AB's Total Assets for the quarter that ended in Dec. 2025 was kr545.1 Mil. Therefore, Bactiguard Holding AB's scaled net operating assets (SNOA) for the quarter that ended in Mar. 2026 was 0.80.
Bactiguard Holding AB Scaled Net Operating Assets Related Terms
Bactiguard Holding AB Scaled Net Operating Assets Historical Data
* Premium members only.
The historical data trend for Bactiguard Holding AB's Scaled Net Operating Assets can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bactiguard Holding AB Scaled Net Operating Assets Chart
CHIX:BACTBS vs ABT, SYK, MDT: Scaled Net Operating Assets Comparison
For the Medical Devices subindustry, Bactiguard Holding AB's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bactiguard Holding AB Scaled Net Operating Assets vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Bactiguard Holding AB's Scaled Net Operating Assets distribution charts can be found below:
* The bar in red indicates where Bactiguard Holding AB's Scaled Net Operating Assets falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Scaled Net Operating Assets of 0.80 mean?
Bactiguard Holding AB (CHIX:BACTBS) has a Scaled Net Operating Assets of 0.80 as of Mar. 2026. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bactiguard Holding AB and its competitors.
Is Bactiguard Holding AB's Scaled Net Operating Assets too high?
Bactiguard Holding AB's current Scaled Net Operating Assets is 0.80. Overall, Bactiguard Holding AB has a GF Score™ of 52/100, reflecting its overall financial health beyond just this single metric.
How does Bactiguard Holding AB's Scaled Net Operating Assets compare to ABT and SYK?
Bactiguard Holding AB's Scaled Net Operating Assets of 0.80 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Scaled Net Operating Assets for a Medical Devices & Instruments company?
A good Scaled Net Operating Assets depends on the Medical Devices & Instruments industry context. However, Scaled Net Operating Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Scaled Net Operating Assets mean?
A high Scaled Net Operating Assets can signal that a stock is expensive relative to its fundamentals. Scaled net operating assets equals current-period operating assets less operating liabilities less prior-period total assets. View historical data on Bactiguard Holding AB and its competitors. Bactiguard Holding AB's current Scaled Net Operating Assets is 0.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bactiguard Holding AB stock overvalued right now?
Bactiguard Holding AB (CHIX:BACTBS) has a current Scaled Net Operating Assets of 0.80. The stock's GF Value™ is kr274.02, compared to a current price of kr128.60 — trading 53.1% below its estimated fair value. The current Scaled Net Operating Assets is 0.80. Bactiguard Holding AB's overall GF Score™ is 52/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Scaled Net Operating Assets calculated?
Scaled Net Operating Assets is calculated from a company's financial statements. For Bactiguard Holding AB (CHIX:BACTBS), the current Scaled Net Operating Assets is 0.80 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bactiguard Holding AB (CHIX:BACTBS) Overvalued in 2026?
Based on GuruFocus' analysis, Bactiguard Holding AB stock appears to be undervalued.
The current stock price of kr128.60 is trading 53.1% below its estimated GF Value™ of kr274.02.
Key valuation signals for CHIX:BACTBS:
Scaled Net Operating Assets: 0.80
GF Value™: kr274.02 vs. price of kr128.60 (53.1% below fair value)
No single metric tells the full story. See the CHIX:BACTBS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bactiguard Holding AB is a medical device company. It is engaged in a MedTech company developing safe and biocompatible technology to prevent medical device-related infections. The technology is based on an ultra-thin noble metal coating that prevents bacterial adhesion and biofilm formation on medical devices. The company focuses on five strategic therapeutic areas wherein infection rates create high medical needs for infection prevention. These areas include Orthopedics, Cardiology, Neurology, Urology, and Vascular Access. Geographically, the company operates in the USA, Malaysia, China, Saudi Arabia, Bangladesh, Sweden, the Czech Republic, and Other countries. The majority of its revenue is generated from the USA region.
52GF Score
Get the complete analysis for CHIX:BACTBS
Scaled Net Operating Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CHIX:BACTBS has been successfully added to your 
